Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.78 USD | +1.54% | +5.13% | +36.17% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 972M |
---|---|---|---|---|---|
Net income 2024 * | -93M | Net income 2025 * | -134M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-10.8
x | P/E ratio 2025 * |
-8.44
x | Employees | 49 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.9% |
Latest transcript on Tyra Biosciences, Inc.
1 day | +1.62% | ||
1 week | +5.13% | ||
Current month | +10.29% | ||
1 month | +27.87% | ||
3 months | -2.13% | ||
6 months | +52.96% | ||
Current year | +36.17% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Bensen
FOU | Founder | 49 | 18-08-01 |
Todd Harris
FOU | Founder | 44 | 18-08-01 |
Alan Fuhrman
DFI | Director of Finance/CFO | 67 | 22-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert More
CHM | Chairman | 56 | 18-10-31 |
Gilla Kaplan
BRD | Director/Board Member | 76 | 19-02-28 |
Todd Harris
FOU | Founder | 44 | 18-08-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +9.07% | - | |
0.00% | 17 M€ | +4.33% | - | |
0.00% | 34 M€ | +3.48% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 18.85 | +1.89% | 144 490 |
24-05-13 | 18.5 | +6.63% | 86,080 |
24-05-10 | 17.35 | -2.31% | 61,461 |
24-05-09 | 17.76 | -1.50% | 39,824 |
24-05-08 | 18.03 | +0.50% | 68,770 |
Delayed Quote Nasdaq, May 14, 2024 at 03:13 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.17% | 972M | |
+28.35% | 48.16B | |
-0.16% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.04% | 25.59B | |
-22.67% | 18.96B | |
+8.47% | 12.92B | |
+29.93% | 12.03B | |
-1.94% | 11.77B |
- Stock Market
- Equities
- TYRA Stock